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22-oxa calcitriol (OCT) is a recently synthesized an-
alog of calcitriol (1,25(0H)2 D 3 ) with potent biologic 
a ctions both in vivo and ill vitro. Because it is consid-
e rably less hypercalcemic than 1,25(0HhD3 when 
given i11 vivo, OCT is of potential use for the treat-
ment of diseases, such as psoriasis, that respond to 
the antiproliferative, prodifferentiating actions of 
1 ,25(0HhD3 • To determine the potential usefulness 
of OCT in hyperproliferative skin diseases, we com-
pared the ability of OCT to that of 1,25(0HhD3 with 
respect to regulation of keratinocyte proliferation 
and differentiation i11 vitro. These studies were per-
formed in serum-free media to eliminate differences 
A !though the classic ro le of1,25 (0H) 2 D is to control calcium and phosphate ~1omeost~s i s, acting pr_inci-pally on bone, gut, and kidney, It ts now apprectated that 1,25(0H)2 D has receptors in and alte rs the function of a wide range of ce lls including the 
dominant cell of the epide rmis, the keratinocyte (recently reviewed 
in [1,2]). Keratinocytes no t o nly respond to exogeno us 
1,25(0H) 2 D w ith changes in pro liferation and differentiation [3- 7]. 
b ut produce 1,25 (0H)2 D [8,9) , suggestin g that 1,25(0H)2 D m ay 
play an autocrine or paracrine ro le in the skin. 
The ability of 1,25 (0H)2 D 3 to regulate epidermal prolife ration 
and differe ntiatio n has been explo ited clinically in the treatm ent 
of psoriasis [10 ,11 ). However, because of the potential risk of 
hyper calcem.ia, hypercalciuria, and neplu·ocalcinosis when using 
1,25(0H) 2D in normocalcemic individuals, analogs of 1,25(0H)zD 
are b eing produced and studied in an effort to obtain compounds 
tha t reta in the abili ty of 1,25(0H) 2 D to inhibit proliferation and 
stimulate differentiation without stimulating intestinal calcium 
transp ort and bo ne resorption. Calcipotriene is o ne such analog that 
shows promise in the treatm ent of psoriasis [1 2, 13). W e have 
studied another promising analog, 22- oxa calcitrio l (OCT), for its 
potential efftcacy in hyperproliferative skin diseases. OCT has been 
fou nd to be at least as potent as l,25(0H)2 D 3 in stimulating 
Manuscript received Apri l 27, 1995; fi nal revision received July 8, 1995; 
accepted fo r publication July 27, 1995. 
Reprint requests to: Dr. Daniel D. Bikle, VAMC (l 'l lN), 4l50 Clement 
Street, San Francisco, CA 94121. 
Abbreviations: DBP, vitamin D- binding protein ; OCT, 22-oxa calcitriol; 
VDR, vitamin D receptor. 
in potency secondary to differences in binding to the 
serum vitamin D-binding protein. We observed that 
OCT was considerably less effective than 1,25(0HhD3 
in inhibiting keratinocyte proliferation and stimulat-
ing differentiation. The decreased potency of OCT 
appeared to be due to decrease d uptake and increased 
catabolism rather than decreased affinity for the v i-
tamin D receptor. We conclude that under the con-
ditions of our experiments OCT was less potent than 
1,25(0HhD3 because it failed to achieve comparable 
concentrations within the cell. Ke}' II!OJ'ds: t l'ausgluta mi-
uaselillvolucrin/com.ified euvelopelrlita.miu D veceptm·. 
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differentiation and inhibiting proliferation of a variety of cells 
cultured in serum contain.ing medium [1 4]. !11 vivo, OCT is effective 
in inhibiting parathyro id ho rmo ne secretion [15), decreas ing tu m or 
growth [1 6), and regulating the primary immun e response [17). 
Much of the apparen t potency of OCT relative to 1,25(0HhD3 
i11 11itro and its relative lack of hypet.:calcemic action i11 11ivo appears 
to be due to comparable affini ty of OCT and 1,25(0HhD3 for the 
intracellular vitamin D receptor (VDR), but much lower b indin g of 
OCT to the circulating vitamin D-binding protein (DBP) [1 8). 
T lus results in a lugher free con centratio n of OCT i11 virro in seru m-
containing m edia and an accelerated cl earance itt t1i11o [1 9]. T hese 
properti es would be expected to increase its potency relative to 
1,25(0H)2 D 3 in 11itro w hen added to serum con taining m edia (20) 
and decrease its potency and/or duration of action on intestina l 
calcium absorptio n and bone resorp tion in tlitlo (21). 
In this study we compa red the ability of OCT and 1 ,25(0H) 2 D, 
to regulate keratinocyte proliferation and diffe ren tiation using 
serum-fi-ee conditio ns to obviate differences in free concen trations . 
We anticipated comparable potency, and were surprised by the 
relative lack of effectiveness of OCT in this system . T hese results 
led us to consider the poss ibility that OCT and 1.25(0H)2 D 3 
underwent substantia lly different me tabo lic fates in keratinocytes. 
Such difl:e rences were found and appear to explain the much lower 
potency of OCT in keratinocyte cul tures. 
MATERIALS AND METHODS 
Materials The OCT and 31-1-0CT were provided as gifts ft·om Dr. 
Yasuho Nishii (Chugai Pharmaceuticals. Tokyo). The 1.25(0H) 0D _, was 
provided as a gift from Dr. M.ilan Uskokovic (Hoffinann-Lal'toche. Nutley. 
NJ). 3 H-1 ,25 (0H) 2 D, was purchased from Arnersham (A rlington Heights, 
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IL). The non-radioactive con1po unds we re so lubili zed in c tlumol and the ir 
con ccntrntio n s determined fro n1 th eir ultrav io let spectra using an ex tin ction 
coefficient at 0Du,.1 of 18,5 00. T he radio labcled compounds we re purified 
by high- perform ance uquid clu·om atography (HPLC ) prior to usc using a 
Zorb ax- Sil co lumn (D uPont, Wilmington , DE) and a concave g radi ent of 
97:3 to 90:10 hexane: isopropano l. T he compounds were added to the cell 
cultures in ethan o l to a final con centration of O.S 1X1. 
Cell Culture Second-passage keracinocytes isolated fi·om neonata l hu-
m an fo reskin s we re u sed in these studies . They were g rown in se run1-frec 
keratinocyte growth mediu m ob tained fi·om C lonetics Corporatio n (San 
D iego, C A) as described previously [22] o r in comparable med ium fro m 
Gibco (Gaithersburg , MD). D etai ls rega rdin g individual experim ents are 
fou nd in th e text and fi gure legends. In all cases the same kera tinocytes w ere 
used fo r a g iven experiment com pa ring OCT to I ,25(01-! )zD, . Un less 
o th erwi se sta ted , th e vita min 0 compo unds were added to th e cel ls 5 d afte r 
p la ti ng , at w hich t ime the ce ll s were approximate ly 70'!1,, conAuent. 
Cellular Proliferation ' 1-1-thymidine incorporation was dete rmin ed as 
previo usly descr ibed [23 ] w ith the fo ll owing modifi cations. T he ce ll s w ere 
grown in 96-well plates with 200 !J.I Gibco ke rati nocyte-se rum-free me-
d ium contai nin g 0.09 mM calciu m for 48 h before the additio n of the 
'1.25(01-l lzD _, or OCT. Incubation continued fo r up to 48 h. During the last 
4 h , 1.5 !J.C i 3 H-th ymidine was added to each we ll. T he amo un t o f 
radioactivity inco rporated in to trichlo roacetic acid precipi tabl e m ate rial was 
quantitated. 
Cornified Envelope Synthesis This assay was performed as previously 
described [6J. The cell s were g ro w n for 5 d in Gibco m edium conta ining 
0.09 mM ca lci um . At this poin t the va ri o us concen tratio ns of OCT o r 
1.25 (0 H) 2 0 , were added. As an additiona l contro l som e ce ll s we re 
switc hed to 1.2 mM ca lcium. Two rni crocuri es pe r mi llil iter of 355-
mcthio nine was then add ed. and the cell s continued thei r incubatio n fo r 48 
h befo re harvest . Two hours before harvest the ce ll s we re exposed to 5 X 
I o-(, M ionon1ycin to ma xin1ize cornified en velope fo rn1ation . T h e cell s 
were then washed three ti mes in phosphate-buffered saline. and the tota l 
radioactivity incorpo rated into trichl o roacetic acid-precipitab le rnatcrinl 
(tota l prote in syn thesis) as well as that inco rp o rated in to sodium dodecyl-
sulfatc (SOS) / d ithiothre ito l inso luble material {cornifi ed enve lopes). were 
dctc rn1in ed. 
Involucrin Protein Levels Ce ll s were grown in Gibco med ium con-
ta ining 0.09 111M calci um un ti l da y 5 at w hich poi n t vario us concentrations 
of OCT o r 1.25(01-1) 2 D3 w ere add ed for an additio nal 48 h. At this po int 
the ce lls were ri nsed o nce w ith Ca ++ . M g + ·' -frcc phos phate bufFered sali ne 
and th en harvested in 2% SDS . Ce ll extra cts were boiled and cen trifu ged at 
12.000 X g fo r 5 min to sediment-inso luble enve lopes . and the sup ernatants 
were co ll ec ted fo r pro te in tnc asurcn1cnt. Eq ui va lent an1o unts of prote in pe r 
sample were separated by SDS-polyacrylamide ge l e lectrophoresis (PAGE) 
(8% po lyacrylamide ge l). b lo tted onto ni troce llulose paper. then immuno-
sta ined using a po lyclo nal anti-invo lu crin (gift from Dr. R obert I'U ce). 
Positive reactio ns w e re visuali zed usin g the e nhanced ch cnlilurnincsccncc 
k it ti·om Ame rsham (A rlin g to n H eights. I L) acco rdi ng to the manufacturer' s 
instru criot ts. 
Transglu tan1inasc Activity T ransglut:uninasc activ ity was d ete rmin ed 
using the m ethod of Schmidt ct a/ 124] . Cells were grown for 5 d in G ibco 
medium conta inin g 0.09 mM calcium , treated for 48 h with various 
concentrations of OCT o r I ,25(0HlzD3 , th en harvested by scrapin g in to SO 
mM Tris-H C I/5 mM etlt ylened iaminctetraacetic ac id , pH 8.0, soni ca ted, 
and centri fuged at 12,000 X g fo r 1 h. Ce ll pe llets were resuspended in to 
assay buffe r (50 mM T ri s-H C I, pH 8.0, 5 mM dithio thre ito l, l 0 mM C aC I2 , 
5 mM ethylenedi aminetetraacetic ac id and 0 . I% Triton X- 1 00) con ta ining 
I J..tCi JH -putrcscine and ·1 m g/ml m eth ylated c-r-cascin. and incuba ted ilt 
3rC for 30 min . The reaction was stopped with the addi t io n of 10% 
tric hl o ro acetic acid, and the 3 H-putrcscinc incorporated into the precip i-
tated casein was quantitated by sci n ti llation spectroscopy. 
Receptor Binding The cytoso l re ceptor assay fo r 1 ,25(01-1) 2 D binding 
was perfo rm ed as previously described [25]. The keratinocytes were 
extracted in bufFer contai ning 50 mM Tris-1-I C I, 300 mM K C I, 1.5 mM 
cthylenediaminetetraacetic acid , 5 mM dithioth reito l, and 1 0 mM sod ium 
mo lybdate. pH 7.4 (TKE DM), an d the 100,000 X g supernatant used as th e 
source of the receptor. T hree hundred eighty microli te rs cytoso l (200 !J.g 
p rotein) were incubated for 8 h on icc with ·1 0 .000 cpm "H-1. 25(01-1) 2 D 
plus up to 3 nM OCT or 1 ,25 (01-1) 2 0 added in 20 fl. l ethano l. Unbound 
radi o activity was rem oved by charcoa l extra ction. and the radioactivity 
rc n1 t\i n in g in the sup ernatan t was dctc rn1incd. Non-specifi c bindi ng was 
subtracted fi·om th e resul ts in performi ng the Scatchard ana lysis. 
T H E JO URN A L OF INVESTIGAT I VE DERMATOLOGY 
Total RNA Preparation and Northern Hybridization Tota l RNA 
was prepared acco rdin g to th e method of C ho m czynski and Sacchi [26). Ln 
brief, ce ll s were d ispersed in lysis solution (4 M guanid ine isothiocyan ate, 25 
mM sodium citrate , 0.5% sa rcosyl, 0.1 M 2- mercaptoethanol) and then 
extracted w ith pheno l-chlo rofo rm , fo llowed by ethano l prec ip itation. For 
Northern ana lysis, RNA was electrophoresed through 1 'Yo agarose-forrnal-
dehyde ge ls, then transferred to H ybond-N + nylo n membranes (Amer-
sham , Arli ngton H eights, IL). T he blots were hybridized with 32 P-Iabeled 
eDNA pro bes for transglu taminase (gift from Dr. R.obert !~i ce), in vo lucrin 
(gift from Dr. H oward Green). and an 185 RNA probe for normalization. 
Results were quanti tated by densitometry o f resu lting autoradiograms. 
Metabolism of OCT and 1,25(0H),D3 The keratinocytes were grown 
to conAuence in keratinocyte g rowth medium conta ining 0 .07 mM calcium. 
' I-I-OCT and 3 H-1.25(0 H )oD3 (0.05 !J.C i/we ll) purifi ed by high-perfor-
mance li quid chro ma tograph y we re added to the cell cultures for variable 
periods of time befo re th e ce ll s and m edia we re separatel y collected. and the 
dish e luted with n1cthah o l to dctcnninc residunl biuding. To tal radioactivity 
in the ce ll s, m ed ia, and di sh e luent were determ ined in 10% aliquots of the 
totnl ; the re mainde r was the n extracted and anal yzed by hig h-pcrforn1ance 
li q uid chromatograph y as previo usly described 19 [. 
Statistical Analysis T he data were analyzed by the appropriate pro-
gra ms in Statsti x (Ana lyti c Soft ware, St . Pau l, MN). In particu lar. th e e fFects 
o f the d ifferen t vitamin D com pou nds were tested for signi fi cance by 
multi va ria te ana lysis o f variance (MAN O VA) tha t inco rporated aU data 
fron t th e cxpcrin1c n t in the ana lys is. 
LliSULTS 
Comparison of OCT and 1,25(0H)2 D 3 Inhibition of Kerati-
nocyte Proliferation The abi li ty of O C T an d 1 ,25 (0H)zD3 to 
inhibit keratinoc yte p ro li ferat ion is sh own in Fig 1. In this exper-
im e nt, the ce ll s w e re harvested 4, 8 , and 24 h after the addition of 
10 - H to 10- c' M OCT and 1 ,25(0 H )zD3 . In other exp e rime nts, 
lower concentratio n s o f th ese compo unds sh owe d no antipro life ra-
t ive activity. A s seen in this exp e rime n t , the inhibition of prolife r-
atio n is d rug, t ime, and d ose dependent. 1 ,25 (0H) 2 D 3 at the 
hi g h est d ose teste d (1 0 - c. M) inhibi ted pro li fera t io n 36% by 4 h and 
8 7% by 24 h. OCT sh owed no sig nifi c ant inhibi t ion at any dose at 
4 h , but th e hig h est d ose (1 0 - c. M) ca u sed a 29°/,, inhibition afte r 24 
h . When ana lyzed by MAN OV A the d ose effect, drug efl'ect, and 
t ime e ffec t were aLI hi g hl y signifi ca n t (p < 0.0001) as were the 
in te r ac ti o n s between drug and dose (p < 0.0001) and time and dose 
(p = 0 .004). 
Comparison of OCT and 1,25(0H)2 D 3 in Their Stimulation 
of Cornified Envelope Formation In this e xpe rime nt (Fig 2) 
t h e vitamin D compounds were adde d 5 d after plating, and the 
ce ll s w e re harvested 4 8 h la te r. The e xperiment was performed in 
m e dia containing 0.09 mM c al c illln except for o n e se t of c ultures in 
whic h t h e c a lc ium co n centratio n was rai sed to 1.2 mM instead of 
addin g one of t h e v itamin D compounds at t he time the v itamin D 
compounds w e re adde d to the oth er c ul tures. These cell s ser ved as 
the positiv e con tro ls. In c reasing the 1,25(0H )zD3 to 10- s M 
resulted in an 88% inc rease in corni fied e nve lope form ation , 
compa rabl e to the 71 % inc rease ca u sed b y raising the ca lcium 
c oncen tration. A s a n a lyzed by ANOVA, t hi s stim ulation was hig hly 
sig nifi can t (p = 0.0015). In contrast , OCT did not sig nifi cantly 
in c re ase cornifi e d e nve lo p e formation (p = 0 .1 0). T h e difference 
between 1 ,25(0H) 2 D 3 and O C T in stimulating co rnifi e d e n ve lo p e 
fo rm ation was hig hl y sig nifi cant (p < 0.0001) as assessed by 
multiple variable ANOVA. 
Comparison of OCT and 1,25(0H)2 D 3 in Their Stimulation 
ofTransglutaminase Activity Transgiu tam in ase activity is re-
q uire d for corn ified e nvelope formation, crosslinkin g solub le sub-
strates su ch as in vo lu crin into the highl y re sistant cornifi e d enve-
lo pe . T h e experiment shown in Fig 3 was pe rforme d u sing ceLl s 
g rown and treated as for the ex periment d e p ic ted in Fig 2. As seen 
in F ig 3, 1 ,25(0H) 2D 3 exe rted a d ose-depende n t stimu lation of 
tran sg lu tamin ase activity (p < 0.0001 ) , in creas ing th e levels of 
ac tivity 11 4% at 10- 8 M. This was compara bl e to t h e 144% increase 
caused b y the c alcium switch . In contrast, OCT rai sed transglu-
tam in ase activ ity on ly 1 6% at 10 - 8 M (p = 0.0415). T h e differe n ces 
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Figure 1. OCT is ~ less potent antiproliferativc agent th~n 
1,25(0H)2D 3 • T he cells were grown in 96-wcll plates in 0.09 mM calcium 
for 48 h before the addi tion of the indica ted concentrations of 1.25(0H) 2D3 
(ope11 bars) or OCT (closed /){Irs). Incubation conti nued for 4. 8. or 24 h before 
harvest. 3 H-thymidinc was added during the last 4 h of the incubation. T he 
cpm incorporated in to the DNA is plotted. T he data arc expressed as mean 
:!:: SD of quadrup licate determinatiom . T he cfrccts of drug. dose. and time 
are all highl y signifi cant (p < 0.000 1} . with I ,25(0 H)o0-' being the more 
potent drug. 
between 1 ,25(0H) 2 0 3 and OCT in their abilities to stimulate 
transglutamin ase activity we re highl y significan t (p < 0.0001 ) . 
Comparison of OCT and 1,25(01-:1)2 0-' in Their Ability to 
R aise lnvolucrin Levels lnvolucrin levels of ce ll s treated for 48 
h with 1 ,25(01-1) 20 3 o r OCT arc sh own in Fig 4. ln volucrin is a 
68-kD protein that runs aberrantly (i.e ., as a hig he r-mo lecul ar-
weig ht species) in SDS-PAGE. T he 140-kD band is the maj o r b and 
imrn unoreacting with o ur anti-invo lucrin antibody, althoug h a 
90-kD band is a lso d etected. T he Western blot is sho wn in the 
upper panel; the densito m etri c tracing of the 140-kD band is shown 
in the lo w e r pan e L ln vo luc rin levels in creased twofo ld fo llowing 
incub ation with 10 - 11 M 1,25 (0 H) 2D, (from 0.7 to 1.6) , and 
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• 1.2mM Ca 
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Figure 2. OCT is less potent than 1,25(0H)zD3 in stimulating 
cornified envelope formation . The cells were gro\vn in 0.09 111M 
calc ium fo r 5 d before the addition of the indicated concemrations of OCT 
or I .25(0H)2 D_, and ·15S-methioninc for an add itiona l 48 h. One set of 
cultures was switc hed to ·1.2 tnM calc iUin rath e r than receivi ng OCT or 
1 .25(0H) 2 D, . The data arc expressed as mean :!:: SEM of t.-ipli cate 
determinations. I ,25(0H)oD_~ but not OCT signi fica ntl y stimulated corni-
fied enve lope formation (p = 0.00 15 and p = 0.0988, respectively). The 
response to I ,25(0 1-1 )2 0 , was dose dependent (p = 0.0004) and signi fi-
cantl y grea ter than that to OCT (p = 0.0008) . 
threefold (to 2. 1) at the hig h est con centratio n of 1 ,25(01-1) 2 0 3 
eva lu ated (10 - 7 M) . OCT also increased in volucrin levels, but th e 
stimulati on at 10 - 7 M (1 .2) was less than that observed at l 0 - 11 M 
1,25(0H)z03 . 
Comparison of OCT a nd 1,25(0H)2 D 3 with Respect to 
Their Ability to Increase mRNA Levels for Transgluatmi-
nase and lnvolncrin T he ability of 1,25(01-1)2D 3 to in crease 
involucrin and transglu taminase activ ity occurs by stimulation of 
ge ne transcrip t io n [27] . The cell s were incubated w ith the indicated 
con centrati ons of OCT o r 1 ,25(0H) 20 3 for 24 h before h arvest 
and analysis of the mRNA levels. T h e results are sh own in Fig 5. 
In this experiment the sam e blot' was an a lyzed fo r in volucrin 
mRNA, transglu taminase mRN A, and 18s RN A. T h e Northern 
analysis is sh own in the upper p ane L T he lower panel shows the 
densitometric data no rmalized to 18s RNA. In this expe rim ent, 
transglutaminase mRNA proved to be more responsive to both 
1 ,25(01-1 )2 0 3 and OCT than in volucrin mRNA. Howeve r , 
1 ,25(01-1) 2 0 3 m ax imally stimul ated the mRN A for involu crin 
> 
!::: 
> 
i=~ (.) .!:: 
<t Q) 
e ~ 0.. 
< Ol 
z E 
0.3 
0.2 
:E c ;: .E 
::) :::: 0.1 
..J 0 
Cl E 
~.e: 
< 
a: 
1-
• CONTROL 
• 1,25-0310-10M 
~ 1 ,25-03 10-9M 
D 1 ,25-03 1 0-BM 
L:J OCT 10-10M 
(!ill OCT 10-9M 
~ OCT10-8M 
• 1.2mM Ca 
Figure 3 . OCT is less potent than 1 ,25 (0H) 2 D_, in stimulating 
transglutarninasc activity. T he cell s were g rown as described in Fig 2 
and then treated for 48 h with the indicated concentrations of OCT, 
I .25 (0H),D_1, or calcitllll . T he results arc expressed as mean :!: SEM of 
tripli cate detcnninations. T he stimulation by I ,25(0 Hh D, was signifocant 
(p < 0.0001 ). dose dependent (p < 0.000 1). and greater than that by OCT 
(p < 0.000 I ) ; OCT had a slight but sign ificant stimulatory effect (p = 
0.0-1 15). 
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Figure 4 . OCT is less potent than 1,25(0H)zD3 in raising involu-
crin levels. T he WfJ shows the Western ana lysis ; th e lwtlmll shows the 
res ults of densitometry. O nl y the results of the upper band arc plotted in the 
bar g raph . l .25(0 H),D 1 stimulated invo lucrin leve ls m o re efFectively than 
did OCT. 
twofo ld (fi·om 0.5 to 1.03) and the transglutaminase mRNA 5.3 
fold (from 0.22 to 1.17) at 10- 111 M . Higher concentrations were 
less effective. In contrast, OCT was max im all y effective at 10- 7 M 
with a 1.58-fold in crease in involucrin mR.NA and a 2.1-fold 
increase in transglu taminase mRNA . These are comparable to or less 
than the stimulation observed with 10- 12-10- 11 M 1 ,25(0H),D3 • 
The differences between OCT and 1 ,25(01-1) 2 0 3 in stimulating the 
mR.NA levels for involucrin and transglu taminase were significant 
(p = 0.006 and 0.003, respectively). 
Affinity of OCT and 1,25(0H)2 D 3 for the VDR To deter-
mine the reason for the markedly lower potency of OCT compared 
to 1 ,25(01-1)2 0 3 in the regulation ofkeratinocyte proliferation and 
differentiation we first compared the ability of OCT and 
1 ,25(0 1-1) 2 0 3 to bind to the intracellul ar VDR as measured by their 
displacement of 3 H-1 ,25(01-1) 2 0 3 from the VDR. These results are 
THE JOUI~AL OF INVESTIGATIVE DEI1.MATOLOGY 
shown in Fig 6. When analyzed by the method ofScatchard, OCT 
had a Kd for the VDR of 215 pM, approximately twice that of 
1 ,25(0H)zD3 (113 pM). T his difFerence would not be expected to 
account for the difFerences seen in the biologic responses. 
Uptake and Metabolism of OCT and 1,25(0H)zD3 We then 
assessed whether the metabolism of OCT in cu lture difFered from 
that of1,25(0H) 2D 3 . These results are shown in Fig 7. As seen in 
A, 1,25(01-1) 20 3 disappeared from the medium at a faster rate than 
OCT. By 1 h, 65% of the 1,25(0H)2D 3 had been removed from the 
medium , and by 2 h only 19'!/o of the original amount of 
1 ,25(0H) 2D 3 was left in the medium. In contrast, at 1 and 2 h 74% 
and 55% of the OCT remained in the medium. Within the first 2 h 
most of the 1,25(0H)2D 3 removed from the medium was fow1d 
intact within the cell ; of the total added, 69% and 58% of the 
1,25(01-1),03 was found within the cells at 1 and 2 h , respectively 
(Fig 7B). In contrast, the amount of intact OCT recovered within 
the cells fai led to rise above 10% of the total added. After 2 h, the 
amount of recoverable OCT in medium plus cells fell below that of 
1,25(0H)2D 3 , indicating more rapid catabolism. After 4 h, most of 
the radioactivity following either 1,25(01-1)2 0 3 or OCT addition 
was found in the medium, but was no longer in tact 1 ,25(0H) 2D 3 
or OCT. With time an increasing fraction of this radioactivity was 
found in the aqueous phase of the extraction. The levels of 
radioactiv ity bound to the dish did not exceed 15% following 
1,25(0H)2 D 3 addition and 10% following OCT addition through-
out the 24 h experiment. T hus, it is apparent that OCT was less 
readily incorporated into keratinocytes and more readily catabo-
lized under the conditions of these experiments. 
DISCUSS ION 
OCT is a recently synthesized analog of1,25(0H)zD3 with limited 
hypercalcemic activity i11 JJiJJo but potent effects on selected biologic 
actions of 1 ,25(0H)2 D 3 including inhibition of parathyroid-hor-
mone secretion [15], tumor-growth suppression [16], and immune 
regulation [17] . Many of the differences in activity between OCT 
and 1 ,25(0H)2 D 3 i11 JJiJJo and i11 vitro have been explained by their 
having comparable affinity for the intracellular VDR but different 
afrinities for the DBP in blood [18-21,28]. /11 vitro, under culture 
conditions that include serum (and, thus, DBP), a higher free 
fraction of OCT would be avai lable to the cell, and OCT would 
appear to be more potent than 1 ,25(0H)zD3 [14, 19,20]. Under 
serum- free conditions, OCT and 1 ,25(0H)2 D 3 would be expected 
to have comparable levels of potency [29-31] . !11 JJitJo, OCT would 
be less bound to DBP and undergo a higher rate of clearance [19] , 
resu lting in a more transient biologic efFect on intestinal ca lcium 
transport [21] or bone resorption. These expectations have been 
rea lized. 
Because of the potential usefulness for a potent, non-hypercal-
cemic 1,25(01-1)2 0 3 analog such as OCT in the treatment of 
hyperproliferative skin diseases, we compared the abilities of OCT 
and 1 ,25(0H) 2D 3 to regulate keratinocyte proliferation and difFer-
entiation. In this study we demonstrated the abi li ty of1 ,25(01-1)20 3 
to suppress kcratinocyte proliferation at doses less than that of 
OCT. This suppression required time, with little inhibition seen 
before 4 h, and was dose dependent with no suppression seen ar 
concentrations of 1,25(0H)2 D 3 less than 10- ~ M . Such high 
concentrations exceed by several orders of magnitude the concen-
trations required to stimulate difrerentiation. 
The process of differentiation examined, cornified envelope 
formation, is unique to the keratinocyte. T his pathway involves the 
crosslinlGng of a number of unique proteins w ithin the keratinocyte 
such as involucrin by a calcium-activated membrane-bound en-
zyme, transglutaminase, to form a highly resistant submembranous 
structure, the cornified envelope. T he cornified envelope gives the 
terminally difFerentiated keratinocyte its name, corneocyte, and 
many of its important protective properties. 1 ,25(0H)zD3 is estab-
lished as an important regulator of keratinocyte differentiation 
[2-7]. W e [32) have recently demonstrated that the ability of 
1 ,25(0H)z03 to stimulate cornified envelope formation is due at 
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least in part to its st irnulntion of in volu crin and transglutaminase 
gene transcri ption. 
In the present stud y, ·1. 25(0H) 2D :~ was found to stimul ate 
cornified e n ve lope formation, transg lutaminase activity, and in-
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Figure 5. OCT is less potent than 1,25(0H),D3 in raising involu-
crin (l) and transglutaminase (TG) mRNA levels. Keratinocytcs were 
grown in 0.07 mM calcium fo r 4 d. switched to 0.03 mM calcium, and the 
various concentrations of OCT or 1,25(0 1-1),0 3 added the fo llowing day. 
T he ce ll s were harvested 24 h later for RNA preparation . The same blot was 
probed for involucrin and transglu taminase mRNA. as well as 18s RNA for 
no nnali zat:ion. The unrnarkcd lane o n the le ft is the ve hicle contro l. Ln11cs 
A-F represent increasing concentrations of OCT or 1.25(0H)2 D, ( I 0 12 to 
I 0 - H Min I o-n iu crc nll:nts) . The top co ntains th e Northcnl data; th e middle 
fllld bottcJIIl conta in the data quantitated by de nsito me try and n ornwli zcd to 
the ISs results. 1.25(0H)2 DJ stimulated the mRNA levels of involucrin and 
transglutaminase more eltcctivcly than did OCT (p = 0.006 and 0.003. 
rcspccti vc I y). 
vo lucrin levels ~t con centrations o f1 0 - 10 M or less. The increase in 
mRNA levels at leas t for transglu taminase was even more sensitive 
w ith increases seen at concentra tions of 10- 12 M 1,25(01-l )zD., . 
OCT was considerably less potent than l ,2 5(0H)2D~ in stimulating 
cornifi e d en ve lope formation, involuc rin levels, transglutaminase 
activ ity, and the rnilNA levels fo r involu crin and transg lutaminase; 
even at the hig hest concentrations of OCT studied (1 o - s-1 0 - 7 M), 
stim ulation of these proteins and activities was less than that seen 
followin g the lowest effective concentration of 1 ,25 (01-1) 20~ ex-
am ined (10 - 12-10- 111 M) . 
One pote n tia l ex planation fo r the lack of potency of OCT in 
keratinocytes is low afrinity fo r the ke ratinocyte VDR. However, 
this was not the case. As has been shown for other tissues 
[18, 29,30,33 ], the VDR fi·om keratinocytcs binds OCT o nly 
slig htl y less well than it binds 1,25(0 1-l )zD,. Therefore, we eval-
uated the cellular uptake and catabolism of OCT in comparison to 
that of 1 ,2 5(01-1) 2 0 3 to determine if reduced uptake or acce lerate d 
metabolism could contribute co the redu ced poten cy of OCT. Our 
results de monstrate that OCT is not o nl y less well taken up by the 
ke ra tinocytes, but that it is more rapidly catabolized. T he net result 
is that for comparable concentrations of OCT and 1 ,25(0H)zD3 
added to the ce lls, the intracellular concentratio ns of OCT never 
achieve a leve l g reater than one seventh that of 1,25(0H) 2 D 3 . 
T hese observations in keratinocytes may not app ly to all ce ll 
types because other cell s do respond well to 0 T, but ce llular 
uptake and m etabolism b y other ·ce ll types have received little 
attention. In an experiment reported recently by Brown r•l a/ [2 1 ]. 
vitamin D deficient rats were injected with radiolabe led OCT o r 
1,2 5(0H)zD 3 . Altho ugh the serum level of OCT fai led to reach the 
same level as that of 1,25(0H)2 D 1 • and di s<1ppeared more rapidl y. 
the le ve l o f OCT in the chromatin fi·om the intestinal mucosa was 
ini tially severalfo ld higher than that of 1 ,25(0H) 2 D 3 . Calcium 
transpo rt and mRNA levels for calbindin were both increased by 
OCT at least transiently in this expe rime nt, comparable to th at b y 
1 ,25(0H)zD3 . T hese d ata sugges t that the intestin al cell m ay not 
limit entry of OCT, alth ough the rapid decrease in OCT levels and 
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Figure 6. OCT has slightly lower affinity for the VDR than 
1,25(0H),D3 • The data show the comparison of the abi li ty of increasing 
amot111ts of 1.25(0H},D 1 and OCT to displnce "H- 1.25 (0H) 2 D 1 from the 
ill tracdlular VDR. The dat:l arc expressed as mean ::!:: SO of trip licate 
dctc nTlinatio ns . 
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Figure 7. OCT is accumulated by keratinocytes less well than 
1,25(0H)2 D 3 a nd is catabolized more rapidly. The cellular uptake and 
metabolism of OCT and 1,25(01-1)20 3 . Labeled OCT or 1,25(01-1),03 was 
added to the cells at time zero. The units of time are hours. The cell s and 
media were extracted separate ly at the indicated times and analyzed for 
intact 1,25(01-1),03 or OCT by high-performance liquid chromatograph y. 
The top shows the levels of 1,25(01-1),03 and OCT in the medium; the 
botto/11 shows the levels in the cell s. Each data point is the mean of duplica te 
di shes , the results of which were within 10% of the mean. 1,25 (01-1),03 
disappears faster from the media and achieves higher concentrations in the 
cell than OCT (p < 0.0001) . Beyond 2 h less intact OCT than 1 ,25(01-1) 2 0 3 
remained in the incubate indicatin g that OCT was more rapidly metabo-
lized than 1.25(01-1)2 0 3 • 
bio logic e ffect in th e intestine is con sistent with in c reased metabo-
li sm . /11 11i11o experime n ts are complicated by the role of DBP in 
regu la ting the free con centra tion s of the OCT and 1 ,25(0HhD3 
avai lable to the cell, however , so that differences in uptake of OCT 
and 1 ,25(0HhD3 cannot b e exclude d from these studies. 
In conclusion , our resu lts indicate that an in te rpretation o f 
re lative poten cies of vitamin D analogs includes not only consid-
eratio n s of relative binding to DBP and VDR, but also an appre-
c iatio n for different rates of cellular uptake and metabolism. In the 
keratinocyte, d ecreased uptake and increased catabolism limi t the 
potency of OCT in regulating proliferation and differe ntiation . 
J,j/ e tlwuk C hugoi Plwnuow ltico fs jin· thl'ir Jiuoucio l support oil(/ pro11i.<io11 qf' key 
rcogc/1/s fo r this stlld)'. The 1/!ork 1/!os of so mpportcd by grn11ts ji-o111 the Notiv11nf 
/u stitutes of H en /til : POl AR39448 nud R01 AR38386. We npprcciote the 
nd111i11istrntille s11pport of Bell"~ Dcln Fumte o11d Vicky Lee. 
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